Med hensyn til indikationen for hypertension fandt CHMP, at valsartan er en etableret terapi for hypertension, og der er ikke nogen væsentlig uoverensstemmelse mellem de nationale produktresuméer.
Regarding the indication in hypertension, the CHMP considered that valsartan is an established therapy for hypertension and there is no substantial discrepancy between the national SPCs.